These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 38990917)
1. Optical coherence tomography of the macular ganglion cell layer in children with neurofibromatosis type 1 is a useful tool in the assessment for optic pathway gliomas. Arnljots U; Nilsson M; Bolzani R; Benassi M; Sandvik U; Munoz DM; Blomgren K; Hellgren K PLoS One; 2024; 19(7):e0305548. PubMed ID: 38990917 [TBL] [Abstract][Full Text] [Related]
2. Investigation of retinal nerve fiber layer thickness and ganglion cell layer-inner plexiform layer thickness in patients with optic pathway gliomas. Hepokur M; Sarici AM Graefes Arch Clin Exp Ophthalmol; 2018 Sep; 256(9):1757-1765. PubMed ID: 29754292 [TBL] [Abstract][Full Text] [Related]
3. Ganglion cell layer-inner plexiform layer thickness and vision loss in young children with optic pathway gliomas. Gu S; Glaug N; Cnaan A; Packer RJ; Avery RA Invest Ophthalmol Vis Sci; 2014 Mar; 55(3):1402-8. PubMed ID: 24519429 [TBL] [Abstract][Full Text] [Related]
4. Correlation of peripapillary retinal nerve fibre layer thickness with visual acuity in paediatric patients affected by optic pathway glioma. Parrozzani R; Miglionico G; Leonardi F; Pulze S; Trevisson E; Clementi M; Opocher E; Licata V; Viscardi E; Pilotto E; Frizziero L; Midena E Acta Ophthalmol; 2018 Dec; 96(8):e1004-e1009. PubMed ID: 30284379 [TBL] [Abstract][Full Text] [Related]
5. Measurements of Retinal Nerve Fiber Thickness and Ganglion Cell Complex in Neurofibromatosis Type 1, with and Without Optic Pathway Gliomas: A Case Series. Sahinoglu-Keskek N; Altan-Yaycioglu R; Canan H; Coban-Karatas M; Erbay A; Yazıcı N; Alkan O Curr Eye Res; 2018 Mar; 43(3):424-427. PubMed ID: 29185816 [TBL] [Abstract][Full Text] [Related]
6. Intra- and inter-visit reproducibility of ganglion cell-inner plexiform layer measurements using handheld optical coherence tomography in children with optic pathway gliomas. Avery RA; Cnaan A; Schuman JS; Chen CL; Glaug NC; Packer RJ; Quinn GE; Ishikawa H Am J Ophthalmol; 2014 Nov; 158(5):916-23. PubMed ID: 25068639 [TBL] [Abstract][Full Text] [Related]
10. Role of visual evoked potentials and optical coherence tomography in the screening for optic pathway gliomas in patients with neurofibromatosis type I. Vagge A; Camicione P; Pellegrini M; Gatti G; Capris P; Severino M; Di Maita M; Panarello S; Traverso CE Eur J Ophthalmol; 2021 Mar; 31(2):698-703. PubMed ID: 32066268 [TBL] [Abstract][Full Text] [Related]
11. Handheld optical coherence tomography during sedation in young children with optic pathway gliomas. Avery RA; Hwang EI; Ishikawa H; Acosta MT; Hutcheson KA; Santos D; Zand DJ; Kilburn LB; Rosenbaum KN; Rood BR; Schuman JS; Packer RJ JAMA Ophthalmol; 2014 Mar; 132(3):265-71. PubMed ID: 24435762 [TBL] [Abstract][Full Text] [Related]
12. Optical coherence tomography in the evaluation of neurofibromatosis type-1 subjects with optic pathway gliomas. Chang L; El-Dairi MA; Frempong TA; Burner EL; Bhatti MT; Young TL; Leigh F J AAPOS; 2010 Dec; 14(6):511-7. PubMed ID: 21168074 [TBL] [Abstract][Full Text] [Related]
13. Investigation of retinal nerve fiber layer thickness in patients with neurofibromatosis-1. Topcu-Yilmaz P; Kasim B; Kiratli H Jpn J Ophthalmol; 2014 Mar; 58(2):172-6. PubMed ID: 24488155 [TBL] [Abstract][Full Text] [Related]
14. Optical Coherence Tomography Identifies Visual Pathway Involvement Earlier than Visual Function Tests in Children with MRI-Verified Optic Pathway Gliomas. Arnljots U; Nilsson M; Sandvik U; Myrberg IH; Munoz DM; Blomgren K; Hellgren K Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053482 [TBL] [Abstract][Full Text] [Related]
15. Ganglion cell analysis at acute episode of nonarteritic anterior ischemic optic neuropathy to predict irreversible damage. A prospective study. De Dompablo E; García-Montesinos J; Muñoz-Negrete FJ; Rebolleda G Graefes Arch Clin Exp Ophthalmol; 2016 Sep; 254(9):1793-800. PubMed ID: 27422787 [TBL] [Abstract][Full Text] [Related]
16. Quantitative MRI demonstrates abnormalities of the third ventricle subventricular zone in neurofibromatosis type-1 and sporadic paediatric optic pathway glioma. Boonzaier NR; Hales PW; D'Arco F; Walters BC; Kaur R; Mankad K; Cooper J; Liasis A; Smith V; O'Hare P; Hargrave D; Clark CA Neuroimage Clin; 2020; 28():102447. PubMed ID: 33038669 [TBL] [Abstract][Full Text] [Related]
17. Retinal ganglion cell layer thinning within one month of presentation for optic neuritis. Kupersmith MJ; Garvin MK; Wang JK; Durbin M; Kardon R Mult Scler; 2016 Apr; 22(5):641-8. PubMed ID: 26362894 [TBL] [Abstract][Full Text] [Related]
18. Correlation of optical coherence tomography parameters with clinical and radiological progression in patients with symptomatic optic pathway gliomas. Fard MA; Fakhree S; Eshraghi B Graefes Arch Clin Exp Ophthalmol; 2013 Oct; 251(10):2429-36. PubMed ID: 23736991 [TBL] [Abstract][Full Text] [Related]
19. Ganglion cell loss in relation to visual disability in multiple sclerosis. Walter SD; Ishikawa H; Galetta KM; Sakai RE; Feller DJ; Henderson SB; Wilson JA; Maguire MG; Galetta SL; Frohman E; Calabresi PA; Schuman JS; Balcer LJ Ophthalmology; 2012 Jun; 119(6):1250-7. PubMed ID: 22365058 [TBL] [Abstract][Full Text] [Related]
20. Visual outcomes after chemotherapy for optic pathway glioma in children with and without neurofibromatosis type 1: results of the International Society of Paediatric Oncology (SIOP) Low-Grade Glioma 2004 trial UK cohort. Falzon K; Drimtzias E; Picton S; Simmons I Br J Ophthalmol; 2018 Oct; 102(10):1367-1371. PubMed ID: 29343527 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]